The number of people living in the United States over the age of 65 is rapidly growing and is projected to reach around 95 million by 2060. The U.S. healthcare system faces many barriers to addressing the complex care needs of older adults in the country. This session highlighted PCORI’s range of investments over the years to promote the health of older adults in the U.S including the funding of comparative clinical effectiveness research and research related projects to engage patients and the broader health and healthcare community, synthesize findings from existing research, and support the dissemination and implementation of effective interventions. PCORI-funded awardees discussed their projects and engaged the audience in an interactive discussion to identify promising directions for future work.

Presentation Slides

Speakers

Breakout Speaker
Headshot of Yawinde Akinbami

Yewande Akinbami, M.D., MPH

  • Program Officer, Clinical Effectiveness & Decision Science Program, PCORI
Remarks Presenter

Sarah Khasawinah, Ph.D.

  • Deputy Staff Director for Ranking Member Mike Braun
Breakout Speaker

Benzi Kluger, M.D., M.S.

  • Professor, Departments of Neurology and Medicine, University of Rochester Medical Center Director, Neuropalliative Care Service Director, Palliative Care Research Center
Breakout Speaker

Tabassum Majid, Ph.D., MAgS

  • Program Officer, Healthcare Delivery & Disparities Program, PCORI
Breakout Speaker

Beth Matthews-Bradshaw, A.B.

  • Vice President for Patient Engagement and Research, Alliance for Aging Research
Breakout Speaker

David Reuben, M.D.

  • Archstone Professor Chief. Division of Geriatrics, David Geffen School of Medicine at UCLA
Breakout Speaker

Kali S. Thomas, Ph.D.

  • Associate Director of Health Services Research, Center for Equity on Aging, School of Nursing, Johns Hopkins University

Tags

Populations Populations PCORI is interested in research that seeks to better understand how different clinical and health system options work for different people. These populations are frequently studied in our portfolio or identified as being of interest by our stakeholders. View Glossary